BCRX BioCryst Pharmaceuticals, Inc. - Common Stock

NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗

$8,90

Kurs · Mai 20, 2026

Fundamentaldaten per Mai 6, 2026

BCRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs

$8.90

Marktkapitalisierung

$1.66B

P/E (TTM)

6.4

EPS (TTM)

$1.21

Umsatz (TTM)

$875M

Dividendenrendite

—

ROE

-97.6%

Verschuldungsgrad

0.0

52W-Spanne

$6 – $11

BCRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $875M

2016-12-31 → 2025-12-31

EPS $1.21

2020-12-31 → 2025-12-31

Freier Cashflow $345M

2016-12-31 → 2025-12-31

Margen 30.2%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl

5-Jahres-Trend

BCRX

Peer-Median

P/E (TTM)

6.4

11.3

P/S (TTM) (K/V (TTM))

1.9

22.0

P/B (K/B)

-13.9

6.3

EV / EBITDA

4.1

—

Price / FCF (Kurs / FCF)

4.8

—

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl

5-Jahres-Trend

BCRX

Peer-Median

Operating Margin (Betriebsgewinnmarge)

39.0%

—

Net Profit Margin (Nettogewinnmarge)

30.2%

-74.2%

ROA

52.5%

-30.3%

ROE

-97.6%

-42.3%

ROIC

-282.4%

—

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl

5-Jahres-Trend

BCRX

Peer-Median

Debt / Equity (Fremdkapital / Eigenkapital)

0.0

78.4

Current Ratio (Liquiditätsgrad)

2.1

8.0

Quick Ratio

1.9

—

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl

5-Jahres-Trend

BCRX

Peer-Median

Revenue YoY (Umsatz YoY)

94.1%

—

Revenue CAGR 3Y (Umsatz CAGR 3J)

47.8%

—

Revenue CAGR 5Y (Umsatz CAGR 5J)

117.9%

—

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl

5-Jahres-Trend

BCRX

Peer-Median

EPS (Diluted) (EPS (Verwässert))

$1.21

—

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl

5-Jahres-Trend

BCRX

Peer-Median

BCRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 16 Analysten

Starker Kauf 5 31,2%
Kauf 10 62,5%
Halten 1 6,2%
Verkauf 0 0,0%
Starker Verkauf 0 0,0%

12-Monats-Kursziel

10 Analysten · 2026-05-18

Median $19.00

Mittelwert $21.30

← Unter allen Zielen $8.90

Tief $13.00

Hoch $32.00

Median-Ziel $19.00 +113,6%

Mittelwert-Ziel $21.30 +139,4%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung

-0.01%

Zeitraum	EPS Actual	EPS est.	Überraschung
31. März 2026	$-0.09	$0.05	-0.14%
31. Dezember 2025	$0.01	$0.04	-0.03%
30. September 2025	$0.06	$0.04	0.02%
30. Juni 2025	$0.04	$0.01	0.03%
31. März 2025	$0.00	$-0.07	0.07%

Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker	Marktkapitalisierung	P/E	Umsatz Vj.	Nettomarge	ROE	Bruttogewinnmarge
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	—
VERA	—	-10.9	—	—	-55.9%	—
IMNM	$2.43B	-8.8	-23.2%	-3060.0%	-47.0%	—
RARE	$2.22B	-3.9	20.2%	-85.4%	-1613.2%	—
MLYS	$2.96B	-15.8	—	—	-32.2%	—
KOD	$1.73B	-6.5	—	—	-202.0%	—
TYRA	$1.41B	-13.1	—	—	-42.7%	—
ADMA	$4.34B	30.4	19.6%	28.8%	33.6%	57.4%
STOK	$1.87B	-264.5	404.5%	-3.7%	-2.0%	—
SRPT	$2.26B	-3.0	15.6%	-32.5%	-57.1%	—

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 16

Jährliche Gewinn- und Verlustrechnung-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$875M	$451M	$331M	$271M	$157M	$18M	$49M	$21M	$25M	$26M	$48M	$14M
Cost of Revenue	$19M	$12M	$4M	$6M	$7M	$2M	$4M	·	$1M	$2M	$1M	$1.0K
R&D Expense	$166M	$175M	$217M	$253M	$209M	$123M	$107M	$85M	$67M	$61M	$73M	$52M
SG&A Expense	$349M	$266M	$214M	$159M	$119M	$68M	$37M	$30M	$14M	$11M	$13M	$7M
Operating Expenses	$534M	$453M	$435M	$419M	$335M	$193M	$148M	$115M	$83M	$75M	$88M	$59M
Operating Income	$341M	$-3M	$-104M	$-148M	$-178M	$-175M	$-99M	$-94M	$-57M	$-49M	$-39M	$-46M
Interest Expense	·	·	$108M	$99M	$59M	$15M	$12M	$9M	$9M	$6M	$5M	$5M
Other Non-op	$-74M	$-84M	$-123M	$-96M	·	·	·	·	·	·	·	·
Pretax Income	$267M	$-87M	$-226M	$-244M	$-182M	$-183M	$-109M	·	·	·	·	·
Income Tax	$4M	$2M	$310.0K	$3M	$2M	$0	$0	$0	$0	$0	$0	·
Net Income	$264M	$-89M	$-227M	$-247M	$-184M	$-183M	$-109M	$-101M	$-66M	$-55M	$-43M	$-45M
EPS (Basic)	$1.26	$-0.43	$-1.18	$-1.33	$-1.03	$-1.09	·	·	·	·	·	·
EPS (Diluted)	$1.21	$-0.43	$-1.18	$-1.33	$-1.03	$-1.09	·	·	·	·	·	·
Shares (Basic)	209,893,000	206,696,000	192,198,000	185,908,000	179,117,000	167,267,000	·	·	·	·	·	·
Shares (Diluted)	218,581,000	206,696,000	192,198,000	185,908,000	179,117,000	167,267,000	115,600,000	103,185,000	84,451,000	73,699,000	72,901,000	66,773,000
EBITDA	$342M	$-1M	$-102M	$-147M	$-177M	$-174M	$-99M	$-93M	·	$-48M	$-39M	$-46M

Bilanz 27

Jährliche Bilanz-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$90M	$105M	$111M	$305M	$504M	$272M	$114M	$27M	$50M	$22M	$29M	$55M
Short-term Investments	$185M	$216M	·	·	·	·	·	·	·	·	·	·
Receivables	$107M	$79M	$57M	$51M	$29M	$9M	$22M	$4M	$6M	$9M	$6M	$4M
Inventory	$5M	$8M	$29M	$28M	$16M	$7M	$0	$2M	·	$500.0K	$2M	$683.0K
Prepaid Expense	$17M	$14M	$20M	$13M	$10M	$6M	$4M	$2M	$1M	$1M	$3M	$6M
Current Assets	$404M	$422M	$496M	$516M	$566M	$324M	$164M	$114M	$125M	$67M	$64M	$89M
PP&E (Net)	$9M	$8M	$8M	$9M	$9M	$7M	$7M	$9M	$10M	$10M	$5M	$207.0K
PP&E (Gross)	$18M	$20M	$19M	$18M	$17M	$14M	$14M	$15M	$15M	$15M	$19M	$14M
Accum. Depreciation	$9M	$12M	$11M	$10M	$8M	$7M	$7M	$6M	$5M	$5M	$14M	$14M
Other Non-current Assets	$6M	$5M	$80.0K	$7M	$6M	$4M	$4M	$978.0K	$2M	$4M	$5M	$6M
Total Assets	$514M	$490M	$517M	$550M	$588M	$335M	$175M	$147M	$178M	$90M	$122M	$137M
Accounts Payable	$16M	$12M	$21M	$14M	$28M	$19M	$14M	$8M	$6M	$4M	$9M	$3M
Accrued Liabilities	$126M	$113M	$103M	$88M	$73M	$34M	$21M	$16M	$13M	$11M	$16M	$11M
Short-term Debt	·	·	·	·	·	$30M	$30M	$29M	$29M	$28M	$28M	$30M
Current Liabilities	$196M	$160M	$150M	$106M	$104M	$106M	$92M	$69M	$75M	$54M	$62M	$57M
Capital Leases	$9M	$8M	$8M	$4M	$6M	$4M	·	·	·	·	·	·
Other Non-current Liabilities	·	·	·	·	·	·	·	$3M	·	·	·	·
Total Liabilities	$633M	$966M	$972M	·	·	·	·	·	·	·	·	·
Long-term Debt	·	·	·	·	$298M	$123M	$50M	$30M	$23M	$23M	·	·
Total Debt	$0	$315M	$303M	$232M	$136M	$150M	$30M	$29M	·	$28M	$30M	$30M
Common Stock	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$984.0K	$738.0K	$734.0K	$720.0K
Paid-in Capital	$1.38B	$1.29B	$1.22B	$1.16B	$1.10B	$1.00B	$877M	$780M	$715M	$567M	$558M	$543M
Retained Earnings	$-1.51B	$-1.77B	$-1.68B	$-1.45B	$-1.21B	$-1.02B	$-841M	$-732M	$-632M	$-566M	$-511M	$-468M
AOCI	$38.0K	$921.0K	$1M	$26.0K	$177.0K	$3.0K	$39.0K	$-297.0K	$-243.0K	$-12.0K	$-206.0K	$-130.0K
Stockholders' Equity	$-119M	$-476M	$-456M	$-295M	$-107M	$-19M	$38M	$49M	$84M	$2M	$48M	$76M
Liabilities + Equity	$514M	$490M	$517M	$550M	$588M	$335M	$175M	$147M	$178M	$90M	$122M	$137M
Shares Outstanding	213,060,000	208,543,000	205,771,000	187,906,000	184,350,000	176,883,000	154,082,000	110,063,000	98,411,000	73,782,000	73,355,000	71,955,000

Cashflow 16

Jährliche Cashflow-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$1M	$1M	$2M	$1M	$777.0K	$748.0K	$724.0K	$770.0K	$704.0K	$483.0K	$180.0K	$177.0K
Stock-based Comp	$85M	$65M	$56M	$45M	$35M	$15M	$18M	$9M	$13M	$8M	$10M	$10M
Deferred Tax	$-1M	$-354.0K	$-682.0K	$11.0K	$-159.0K	·	·	·	·	·	·	·
Other Non-cash	$-2M	$-29M	$75M	$39M	$6M	$30M	$870.0K	$-1M	·	$-7M	$20M	$-4M
Operating Cash Flow	$347M	$-52M	$-95M	$-162M	$-142M	$-135M	$-90M	$-93M	$-41M	$-53M	$-13M	$-39M
CapEx	$2M	$1M	$2M	$1M	$2M	$514.0K	$343.0K	$366.0K	$328.0K	$5M	$5M	$106.0K
Investing Cash Flow	$-14M	$53M	$-131M	$-128M	$16M	$-7M	$78M	$5M	$-65M	$23M	$-18M	·
Debt Issued	$0	$0	$300M	$73M	$0	·	·	·	·	·	·	·
Net Debt Issued	$-300M	$0	$300M	·	·	·	·	·	·	·	·	·
Stock Issued	·	·	$0	$0	$50M	$93M	$58M	$53M	$134M	·	·	$107M
Net Stock Activity	·	·	$0	$0	$50M	$93M	$58M	$53M	·	·	·	$107M
Financing Cash Flow	$-350M	$-6M	$32M	$88M	$360M	$301M	$99M	$63M	$136M	$23M	$5M	·
Net Change in Cash	$-15M	$-6M	$-194M	$-201M	$233M	$159M	$87M	$-25M	$30M	$-7M	$-26M	$33M
Taxes Paid	$3M	$2M	$1M	·	·	·	·	·	·	·	·	·
Free Cash Flow	$345M	$-53M	$-97M	$-163M	$-145M	$-138M	$-90M	$-93M	·	$-59M	$-18M	$-39M
Levered FCF	·	·	$-206M	$-263M	$-205M	$-152M	·	·	·	·	·	·

Rentabilität 7

Jährliche Rentabilität-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	39.0%	-0.56%	-31.3%	-54.8%	-113.1%	-981.1%	-203.7%	-456.2%	·	-184.4%	-81.7%	-336.4%
Net Margin	30.2%	-19.7%	-68.4%	-91.2%	-117.1%	-1026.4%	-223.0%	-490.2%	·	-209.2%	-89.1%	-332.1%
Pretax Margin	30.6%	-19.3%	-68.3%	-90.2%	-115.7%	-1026.4%	·	·	·	·	·	·
EBITDA Margin	39.1%	-0.29%	-30.8%	-54.3%	-112.6%	-976.9%	-202.2%	-452.5%	·	-182.6%	-81.4%	-335.0%
ROA	52.5%	-17.6%	-42.5%	-43.4%	-39.9%	-71.7%	-67.6%	-62.3%	·	-52.0%	-32.9%	-48.7%
ROE	-97.6%	18.8%	52.3%	92.0%	144.9%	-2543.5%	7257.4%	-165.8%	·	-223.7%	-69.8%	-121.3%
ROIC	-282.4%	1.6%	68.2%	238.4%	-618.4%	-133.9%	·	·	·	·	·	·

Liquidität & Solvenz 5

Jährliche Liquidität & Solvenz-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	2.1	2.6	3.3	4.9	5.5	3.1	1.8	1.6	·	1.2	1.0	1.5
Quick Ratio	1.9	1.1	1.1	3.4	5.1	2.7	1.5	0.4	·	0.6	0.5	0.9
Debt / Equity	0.0	-0.7	-0.7	-0.8	-1.3	-7.8	0.8	0.6	·	17.9	0.6	0.4
LT Debt / Equity	0.0	-0.7	-0.7	-0.8	-1.3	-6.2	·	·	·	·	·	·
Interest Coverage	·	·	-1.0	-1.5	-3.0	-12.1	-8.4	-10.3	·	-7.5	-7.6	-9.2

Effizienz 3

Jährliche Effizienz-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	1.7	0.9	0.6	0.5	0.3	0.1	0.3	0.1	·	0.2	0.4	0.1
Inventory Turnover	2.8	0.4	0.2	0.3	0.6	0.4	·	·	·	2.2	1.2	0.0
Receivables Turnover	9.4	6.6	6.2	6.8	8.3	1.2	3.7	4.0	·	3.5	9.6	·

Pro Aktie 5

Jährliche Pro Aktie-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$-0.56	$-2.28	$-2.21	$-1.57	$-0.58	$-0.11	$0.25	$0.45	·	$0.02	$0.65	$1.05
Revenue / Share	$4.00	$2.18	$1.72	$1.46	$0.88	$0.11	$0.42	$0.20	·	$0.36	$0.66	·
Cash Flow / Share	$1.59	$-0.25	$-0.49	$-0.87	$-0.79	$-0.82	$-0.77	$-0.90	·	$-0.73	$-0.18	·
Cash / Share	$0.42	$0.50	$0.54	$1.62	$2.74	$1.54	$0.74	$0.24	·	$0.30	$0.39	$0.76
EPS (TTM)	$1.21	$-0.43	$-1.18	$-1.33	$-1.03	$-1.09	$-0.61	$-0.61	$-0.61	$-0.61	$-0.60	·

Wachstumsraten 3

Jährliche Wachstumsraten-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	94.1%	36.0%	22.4%	72.3%	782.4%	·	·	·	·	·	·	·
Revenue CAGR 3Y	47.8%	42.1%	165.0%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	117.9%	·	·	·	·	·	·	·	·	·	·	·

Bewertung (TTM) 13

Jährliche Bewertung (TTM)-Daten für BCRX
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$875M	$451M	$331M	$271M	$157M	$18M	$49M	$21M	$25M	$26M	$48M	$14M
Net Income TTM	$264M	$-89M	$-227M	$-247M	$-184M	$-183M	$-109M	$-101M	$-66M	$-55M	$-43M	$-45M
Market Cap	$1.66B	$1.57B	$1.23B	$2.16B	$2.55B	$1.32B	$532M	$888M	·	$467M	$757M	$875M
Enterprise Value	$1.39B	$1.78B	$1.43B	$2.08B	$2.18B	$1.20B	$447M	$891M	·	$473M	$758M	$850M
P/E	6.4	-17.5	-5.1	-8.6	-13.4	-6.8	-5.7	-13.2	-8.0	-10.4	-17.2	·
P/S	1.9	3.5	3.7	8.0	16.2	74.0	10.9	43.0	·	17.7	15.7	64.3
P/B	-13.9	-3.3	-2.7	-7.3	-23.9	-68.4	13.9	18.0	·	296.0	15.9	11.6
P / Cash Flow	4.8	-30.1	-13.0	-13.3	-18.0	-9.6	-5.9	-9.6	·	-8.7	-57.7	-22.7
P / FCF	4.8	-29.5	-12.7	-13.2	-17.7	-9.6	-5.9	-9.6	·	-8.0	-41.5	-22.6
EV / EBITDA	4.1	-1371.2	-14.0	-14.2	-12.3	-6.9	-4.5	-9.5	·	-9.8	-19.3	-18.7
EV / FCF	4.0	-33.5	-14.6	-12.8	-15.1	-8.7	-5.0	-9.6	·	-8.1	-41.6	-22.0
EV / Revenue	1.6	3.9	4.3	7.7	13.9	67.1	9.2	43.1	·	18.0	15.7	62.5
Earnings Yield	15.5%	-5.7%	-19.7%	-11.6%	-7.4%	-14.6%	-17.7%	-7.6%	-12.4%	-9.6%	-5.8%	·

Gewinn- und Verlustrechnung 16

Vierteljährliche Gewinn- und Verlustrechnung-Daten für BCRX
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$156M	$407M	$159M	$163M	$146M	$132M	$117M	$109M	$93M	$93M	$87M	$82M	$69M	$80M	$76M	$66M
Cost of Revenue	$5M	$10M	$2M	$3M	$5M	$6M	$3M	$2M	$1M	$2M	$1M	$894.0K	$931.0K	$2M	$4M	$246.0K
R&D Expense	$60M	$41M	$45M	$43M	$37M	$49M	$41M	$38M	$46M	$70M	$47M	$51M	$48M	$73M	$53M	$62M
SG&A Expense	$95M	$96M	$83M	$87M	$82M	$81M	$65M	$61M	$59M	$65M	$51M	$51M	$48M	$50M	$37M	$38M
Operating Expenses	$858M	$146M	$130M	$134M	$124M	$136M	$109M	$101M	$107M	$136M	$99M	$103M	$97M	$126M	$93M	$100M
Operating Income	$-702M	$260M	$30M	$30M	$21M	$-5M	$8M	$9M	$-14M	$-43M	$-12M	$-21M	$-28M	$-46M	$-17M	$-35M
Interest Expense	·	·	·	·	·	·	·	$25M	$25M	·	$27M	$29M	$27M	·	$25M	$24M
Other Non-op	$-1M	$-12M	$-17M	$-23M	$0	$-21M	$-21M	$-21M	$-21M	·	·	·	·	·	·	·
Pretax Income	$-721M	$248M	$12M	$6M	$758.0K	$-26M	$-13M	$-13M	$-35M	$-63M	$-36M	$-75M	$-53M	$-71M	$-41M	$-58M
Income Tax	$1M	$2M	$-769.0K	$1M	$726.0K	$804.0K	$586.0K	$172.0K	$365.0K	$-1M	$330.0K	$740.0K	$671.0K	$76.0K	$2M	$856.0K
Net Income	$-722M	$246M	$13M	$5M	$32.0K	$-27M	$-14M	$-13M	$-35M	$-62M	$-36M	$-75M	$-53M	$-72M	$-43M	$-59M
EPS (Basic)	$-2.98	$1.18	$0.06	$0.02	$0.00	$-0.13	$-0.07	$-0.06	$-0.17	$-0.31	$-0.19	$-0.40	$-0.28	$-0.38	$-0.23	$-0.32
EPS (Diluted)	$-2.98	$1.13	$0.06	$0.02	$0.00	$-0.13	$-0.07	$-0.06	$-0.17	$-0.31	$-0.19	$-0.40	$-0.28	$-0.38	$-0.23	$-0.32
Shares (Basic)	242,258,000	-418,684,000	210,176,000	209,519,000	208,882,000	-412,698,000	206,905,000	206,425,000	206,064,000	-375,073,000	189,644,000	189,118,000	188,509,000	-370,775,000	186,180,000	185,605,000
Shares (Diluted)	242,258,000	-436,451,000	219,885,000	219,886,000	215,261,000	-412,698,000	206,905,000	206,425,000	206,064,000	-375,073,000	189,644,000	189,118,000	188,509,000	-370,775,000	186,180,000	185,605,000
EBITDA	$-702M	·	$30M	$30M	$22M	·	$8M	$9M	$-14M	·	$-12M	$-21M	$-28M	·	$-17M	$-35M

Bilanz 24

Vierteljährliche Bilanz-Daten für BCRX
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$172M	$90M	$84M	$88M	$105M	$105M	$97M	$78M	$84M	$111M	$151M	$146M	$155M	$305M	$247M	$273M
Short-term Investments	$67M	$185M	$129M	$172M	$190M	$216M	·	·	·	·	·	·	·	·	·	·
Receivables	$109M	$107M	$91M	$91M	$93M	$79M	$72M	$69M	$61M	·	$54M	$58M	$49M	·	$43M	$41M
Inventory	$6M	$5M	$5M	$5M	$7M	$8M	$8M	$4M	$30M	·	$30M	$27M	$27M	·	$27M	$23M
Prepaid Expense	$19M	$17M	$17M	$13M	$14M	$14M	$16M	$16M	$18M	·	$20M	$14M	$15M	·	$11M	$11M
Current Assets	$374M	$404M	$356M	$398M	$410M	$422M	$427M	$363M	$447M	·	$502M	$511M	$491M	·	$509M	$495M
PP&E (Net)	$9M	$9M	$8M	$8M	$8M	$8M	$7M	$8M	$8M	·	$9M	$8M	$8M	·	$8M	$9M
PP&E (Gross)	·	$18M	·	·	·	$20M	·	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	$9M	·	·	·	$12M	·	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$20M	$6M	$4M	$4M	$5M	$5M	$16M	$12M	$13M	·	$11M	$7M	$7M	·	$7M	$7M
Total Assets	$465M	$514M	$446M	$457M	$480M	$490M	$491M	$472M	$468M	·	$523M	$530M	$510M	·	$559M	$511M
Accounts Payable	$11M	$16M	$6M	$9M	$10M	$12M	$13M	$8M	$12M	·	$11M	$14M	$6M	·	$9M	$12M
Accrued Liabilities	$119M	$126M	$119M	$107M	$93M	$113M	$104M	$90M	$79M	·	$77M	$75M	$75M	·	$69M	$80M
Current Liabilities	$195M	$196M	$190M	$177M	$140M	$160M	$154M	$129M	$120M	·	$91M	$93M	$85M	·	$82M	$95M
Capital Leases	$11M	$9M	$8M	$8M	$8M	$8M	$8M	$8M	$9M	·	$10M	$6M	$6M	·	$6M	$6M
Total Liabilities	$1.02B	$633M	$834M	$879M	$932M	$966M	$960M	·	·	·	·	·	·	·	·	·
Total Debt	$395M	·	$194M	$243M	$315M	·	$314M	$314M	$308M	·	$298M	$293M	$233M	·	$224M	$145M
Common Stock	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$2M	$2M	$2M	·	$2M	$2M
Paid-in Capital	$1.67B	$1.38B	$1.36B	$1.34B	$1.31B	$1.29B	$1.27B	$1.25B	$1.24B	·	$1.21B	$1.19B	$1.18B	·	$1.14B	$1.13B
Retained Earnings	$-2.23B	$-1.51B	$-1.75B	$-1.76B	$-1.77B	$-1.77B	$-1.74B	$-1.73B	$-1.72B	·	$-1.62B	$-1.58B	$-1.51B	·	$-1.38B	$-1.34B
AOCI	$-368.0K	$38.0K	$1M	$2M	$1M	$921.0K	$2M	$557.0K	$771.0K	·	$800.0K	$690.0K	$585.0K	·	$-98.0K	$15.0K
Stockholders' Equity	$-554M	$-119M	$-388M	$-422M	$-452M	$-476M	$-469M	$-476M	$-476M	$-456M	$-411M	$-389M	$-328M	$-295M	$-243M	$-213M
Liabilities + Equity	$465M	$514M	$446M	$457M	$480M	$490M	$491M	$472M	$468M	·	$523M	$530M	$510M	·	$559M	$511M
Shares Outstanding	254,014,000	213,060,000	210,522,000	209,905,000	209,208,000	208,543,000	207,119,000	206,629,000	206,347,000	205,771,000	189,803,000	189,491,000	188,883,000	187,906,000	186,411,000	185,876,000

Cashflow 14

Vierteljährliche Cashflow-Daten für BCRX
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	·	$394.0K	$335.0K	$329.0K	$331.0K	$309.0K	$311.0K	$320.0K	$306.0K	$423.0K	$420.0K	$407.0K	$405.0K	$396.0K	$389.0K	$335.0K
Stock-based Comp	$16M	$24M	$19M	$21M	$21M	$21M	$17M	$13M	$14M	$16M	$12M	$13M	$14M	$15M	$10M	$10M
Amort. of Intangibles	$600.0K	·	·	·	$0	·	·	·	·	·	·	·	·	·	·	·
Other Non-cash	·	·	·	·	$-49M	·	·	·	$-32M	·	·	·	$-9M	·	·	·
Operating Cash Flow	$-62M	$292M	$42M	$41M	$-28M	$-5M	$8M	$-1M	$-54M	$-9M	$-20M	$-19M	$-48M	$-24M	$-32M	$-28M
CapEx	$403.0K	$802.0K	$1M	$179.0K	$143.0K	$675.0K	$59.0K	$155.0K	$235.0K	$554.0K	$987.0K	$467.0K	$160.0K	$526.0K	$175.0K	$244.0K
Investing Cash Flow	$-269M	$-83M	$14M	$29M	$27M	$18M	$8M	$-2M	$29M	$-28M	$23M	$-19M	$-107M	$77M	$-70M	$-97M
Debt Issued	$400M	·	·	·	$0	$0	$0	·	·	$0	$0	·	·	$0	$73M	·
Net Debt Issued	$400M	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$413M	$-218M	$-59M	$-74M	$529.0K	$-4M	$1M	$-2M	$-1M	$-3M	$1M	$29M	$5M	$4M	$76M	$147.0K
Net Change in Cash	$82M	·	·	·	$558.0K	$7M	$19M	$-6M	$-26M	$-40M	$5M	$-9M	$-150M	$58M	$-26M	$-125M
Taxes Paid	$1M	·	·	·	$1.0K	·	·	·	·	·	·	·	·	·	·	·
Free Cash Flow	$-62M	·	·	·	$-28M	·	·	·	$-54M	·	·	·	$-48M	·	·	·
Levered FCF	·	·	·	·	·	·	·	·	$-79M	·	·	·	$-75M	·	·	·

Rentabilität 7

Vierteljährliche Rentabilität-Daten für BCRX
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	-448.6%	·	18.6%	18.2%	14.6%	·	6.6%	8.0%	-15.6%	·	-13.7%	-25.1%	-41.3%	·	-23.0%	-53.0%
Net Margin	-461.5%	·	8.1%	3.1%	0.02%	·	-12.0%	-11.6%	-38.1%	·	-41.7%	-91.3%	-77.5%	·	-56.1%	-89.8%
Pretax Margin	-460.8%	·	7.6%	4.0%	0.52%	·	-11.5%	-11.4%	-37.8%	·	-41.3%	-90.4%	-76.6%	·	-54.1%	-88.5%
EBITDA Margin	-448.6%	·	18.6%	18.2%	14.8%	·	6.6%	8.0%	-15.3%	·	-13.7%	-25.1%	-40.7%	·	-23.0%	-53.0%
ROA	-152.8%	·	2.8%	1.1%	0.01%	·	-2.8%	-2.5%	-7.2%	·	-6.7%	-14.5%	-10.3%	·	-10.3%	-14.9%
ROE	143.5%	·	-3.0%	-1.1%	-0.01%	·	3.2%	2.9%	8.8%	·	11.1%	25.0%	21.7%	·	21.8%	36.9%
ROIC	442.9%	·	-16.3%	-13.1%	-0.66%	·	-5.2%	-5.5%	8.7%	·	10.7%	21.9%	30.0%	·	96.3%	51.3%

Liquidität & Solvenz 5

Vierteljährliche Liquidität & Solvenz-Daten für BCRX
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	1.9	·	1.9	2.2	2.9	·	2.8	2.8	3.7	·	5.5	5.5	5.8	·	6.2	5.2
Quick Ratio	1.8	·	1.6	2.0	2.8	·	1.1	1.1	1.2	·	2.3	2.2	2.4	·	3.5	3.3
Debt / Equity	-0.7	·	-0.5	-0.6	-0.7	·	-0.7	-0.7	-0.6	·	-0.7	-0.8	-0.7	·	-0.9	-0.7
LT Debt / Equity	-0.7	·	-0.5	-0.6	-0.7	·	-0.7	-0.7	-0.6	·	-0.7	-0.8	-0.7	·	-0.9	-0.7
Interest Coverage	·	·	·	·	·	·	·	0.4	-0.6	·	-0.4	-0.7	-1.0	·	-0.7	-1.4

Effizienz 3

Vierteljährliche Effizienz-Daten für BCRX
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.3	·	0.3	0.4	0.3	·	0.2	0.2	0.2	·	0.2	0.2	0.1	·	0.2	0.2
Inventory Turnover	0.8	·	0.3	0.6	0.2	·	0.2	0.1	0.0	·	0.0	0.0	0.0	·	0.2	0.0
Receivables Turnover	1.5	·	1.9	2.0	1.9	·	1.9	1.7	1.7	·	1.8	1.7	1.6	·	2.2	1.9

Pro Aktie 5

Vierteljährliche Pro Aktie-Daten für BCRX
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$-2.18	·	$-1.84	$-2.01	$-2.16	·	$-2.26	$-2.30	$-2.31	·	$-2.17	$-2.05	$-1.74	·	$-1.30	$-1.15
Revenue / Share	$0.65	·	$0.72	$0.74	$0.68	·	$0.57	$0.53	$0.45	·	$0.46	$0.44	$0.36	·	$0.41	$0.35
Cash Flow / Share	$-0.26	·	·	·	$-0.13	·	·	·	$-0.26	·	·	·	$-0.25	·	·	·
Cash / Share	$0.68	·	$0.40	$0.42	$0.50	·	$0.47	$0.38	$0.41	·	$0.80	$0.77	$0.82	·	$1.32	$1.47
EPS (TTM)	$-2.90	·	$0.01	$-0.11	$-0.30	·	$-0.49	$-0.82	$-1.04	·	$-1.10	$-1.23	$-1.23	·	$-1.28	$-1.29

Bewertung (TTM) 13

Vierteljährliche Bewertung (TTM)-Daten für BCRX
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$625M	·	$585M	$535M	$465M	·	$406M	$371M	$331M	·	$314M	$293M	$260M	·	$232M	$206M
Net Income TTM	$-704M	·	$4M	$-22M	$-62M	·	$-98M	$-160M	$-200M	·	$-207M	$-230M	$-229M	·	$-234M	$-235M
Market Cap	$2.42B	·	$1.60B	$1.88B	$1.57B	·	$1.57B	$1.28B	$1.05B	·	$1.34B	$1.33B	$1.58B	·	$2.35B	$1.97B
Enterprise Value	$2.58B	·	$1.58B	$1.86B	$1.59B	·	$1.79B	$1.51B	$1.27B	·	$1.49B	$1.48B	$1.65B	·	$2.33B	$1.84B
P/E	-3.3	·	759.0	-81.5	-25.0	·	-15.5	-7.5	-4.9	·	-6.4	-5.7	-6.8	·	-9.8	-8.2
P/S	3.9	·	2.7	3.5	3.4	·	3.9	3.4	3.2	·	4.3	4.6	6.1	·	10.1	9.5
P/B	-4.4	·	-4.1	-4.5	-3.5	·	-3.4	-2.7	-2.2	·	-3.3	-3.4	-4.8	·	-9.7	-9.2
P / Cash Flow	-39.1	·	·	·	-57.0	·	·	·	-19.5	·	·	·	-33.2	·	·	·
P / FCF	-38.9	·	·	·	-56.7	·	·	·	-19.4	·	·	·	-33.0	·	·	·
EV / EBITDA	-3.7	·	53.4	62.6	73.7	·	232.9	172.6	-89.7	·	-125.1	-71.5	-59.0	·	-133.3	-52.9
EV / FCF	-41.4	·	·	·	-57.5	·	·	·	-23.6	·	·	·	-34.7	·	·	·
EV / Revenue	4.1	·	2.7	3.5	3.4	·	4.4	4.1	3.8	·	4.8	5.1	6.4	·	10.0	8.9
Earnings Yield	-30.5%	·	0.13%	-1.2%	-4.0%	·	-6.5%	-13.3%	-20.5%	·	-15.5%	-17.5%	-14.8%	·	-10.2%	-12.2%

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Umsatz	$875M	$451M	$331M	$271M	$157M
Betriebsgewinnmarge %	39.0%	-0.56%	-31.3%	-54.8%	-113.1%
Nettoergebnis	$264M	$-89M	$-227M	$-247M	$-184M
Verwässerte EPS	$1.21	$-0.43	$-1.18	$-1.33	$-1.03

Bilanz

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Fremdkapital / Eigenkapital	0.0	-0.7	-0.7	-0.8	-1.3
Liquiditätsgrad	2.1	2.6	3.3	4.9	5.5
Quick Ratio	1.9	1.1	1.1	3.4	5.1

Cashflow

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Freier Cashflow	$345M	$-53M	$-97M	$-163M	$-145M

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

RBC Capital erhöht PT für BioCryst Pharmaceuticals (BCRX) als Teil der Q1 2026 Ergebniserwartung in Biotech Yahoo Finance · 2 Wochen, 4 Tage vor
BioCryst (BCRX) Rallyt um 7,10 % aufgrund von Übernahmegerüchten Yahoo Finance · 1 Monat, 4 Wochen vor
BioCryst Pharmaceuticals, Inc. (BCRX) Eine gute Aktie zum Kauf jetzt? Yahoo Finance · 1 Monat, 4 Wochen vor

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

BCRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

BCRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

Gleitende Durchschnitte und Überlagering

Volumen

Oszillatoren

Momentum und Trend

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

BCRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

12-Monats-Kursziel

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten